Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RASBURICASE for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where RASBURICASE was used for B-cell lymphoma.

Most Reported Side Effects for RASBURICASE

Side Effect Reports % Deaths Hosp.
Tumour lysis syndrome 116 13.1% 46 38
Methaemoglobinaemia 92 10.4% 8 70
Off label use 90 10.2% 29 30
Product use in unapproved indication 76 8.6% 10 65
Bacterial infection 75 8.5% 9 75
Fungal infection 73 8.3% 7 73
Cellulitis 72 8.1% 6 72
Clostridium difficile colitis 72 8.1% 6 72
Lymphoid tissue hypoplasia 72 8.1% 6 72
Lymphopenia 72 8.1% 6 72
Drug ineffective 71 8.0% 22 39
Thymus hypoplasia 70 7.9% 6 70
Disseminated aspergillosis 67 7.6% 6 67
Cytomegalovirus viraemia 65 7.3% 6 65
Haemolytic anaemia 57 6.4% 1 42

Other Indications for RASBURICASE

Tumour lysis syndrome (151) Prophylaxis (107) Product used for unknown indication (99) Hyperuricaemia (78) Acute lymphocytic leukaemia (41) Acute myeloid leukaemia (18) Non-hodgkin's lymphoma (16) Blood uric acid increased (15) Blood uric acid (12) Blood uric acid abnormal (12)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

RASBURICASE Full Profile All B-cell lymphoma Drugs RASBURICASE Demographics RASBURICASE Timeline